CVS HEALTH Corp (CVS) earnings date
Feb 10, 2027, before open estimated
Estimated from the company's SEC filing cadence. The company has not confirmed it. Companies usually announce two to four weeks ahead.
- Fiscal period
- Q4 FY2026
- Confidence
- 52% chance of landing within a day
- Source
- Filing history on EDGAR
- Last checked
- 2026-11-19
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
How this company behaves
| Announces its report date | Not enough announcements on file yet to say |
| Reports after the quarter ends | 36 days, typically, give or take 5 (last 8 releases) |
Last 8 releases
| Period | Released | Timing | Days after period end | Filing |
|---|---|---|---|---|
| Q3 FY2026 | Wed, Nov 4, 2026 | before open | 35 | 8-K |
| Q2 FY2026 | Wed, Aug 5, 2026 | before open | 36 | 8-K |
| Q1 FY2026 | Wed, May 6, 2026 | before open | 36 | 8-K |
| Q4 FY2025 | Tue, Feb 10, 2026 | before open | 41 | 8-K |
| Q3 FY2025 | Wed, Oct 29, 2025 | before open | 29 | 8-K |
| Q2 FY2025 | Thu, Jul 31, 2025 | before open | 31 | 8-K |
| Q1 FY2025 | Thu, May 1, 2025 | before open | 31 | 8-K |
| Q4 FY2024 | Wed, Feb 12, 2025 | before open | 43 | 8-K |
What they guided beta
| Q3 FY2026 | "Document Exhibit 99.1 CVS HEALTH CORPORATION REPORTS THIRD QUARTER 2026 RESULTS AND RAISES FULL-YEAR 2026 GUIDANCE" exhibit |
| Q3 FY2026 | "Raising full-year 2026 guidance:" exhibit |
| Q3 FY2026 | "Cash flow from operations guidance to at least $15.5 billion from at least $11.5 billion WOONSOCKET, RHODE ISLAND, November 4, 2026 - CVS Health Corporation (NYSE: CVS) today announced operating results for the three months ended September 30, 2026." exhibit |
| Q3 FY2026 | "We continue to advance our strategy by improving the consumer experience, lowering health care costs, and connecting care for the people we serve.” - David Joyner, CVS Health Chairman and CEO Three Months Ended September 30, Year Ending December 31, In billions, except per share amounts 2026 2025 2026 Projected Total revenues $ 108.4 $ 102.9 At least $420.0 Diluted earnings (loss) per share $ 1.68 $ (3.13) At least $6.98 Adjusted EPS (2) $ 2.09 $ 1.60 At least $8.20 Third quarter GAAP diluted earnings per share of $1.68 increased from a loss per share of $3.13 in the prior year, reflecting th" exhibit |
| Q3 FY2026 | "The Company is increasing its full-year 2026 GAAP diluted EPS, Adjusted EPS and cash flow from operations guidance to reflect increases in the Health Care Benefits and Pharmacy & Consumer Wellness segments, while maintaining a cautious view for the remainder of the year in light of continued elevated cost trends and the potential for macro headwinds. 1 Consolidated third quarter results Three Months Ended September 30, Nine Months Ended September 30, In millions, except per share amounts 2026 2025 Change 2026 2025 Change Total revenues $ 108,399 $ 102,871 $ 5,528 $ 314,921 $ 296,374 $ 18,547 " exhibit |
| Q2 FY2026 | "Document Exhibit 99.1 CVS HEALTH CORPORATION REPORTS STRONG SECOND QUARTER 2026 RESULTS AND RAISES FULL-YEAR 2026 GUIDANCE" exhibit |
| Q2 FY2026 | "Raising full-year 2026 guidance:" exhibit |
| Q2 FY2026 | "Cash flow from operations guidance to at least $11.5 billion from at least $9.5 billion WOONSOCKET, RHODE ISLAND, August 5, 2026 - CVS Health Corporation (NYSE: CVS) today announced operating results for the three months ended June 30, 2026." exhibit |
| Q2 FY2026 | "We uniquely enable what our customers want the most: simple, connected and convenient access to affordable, quality healthcare, where, when, and how they want it.” - David Joyner, CVS Health Chairman and CEO Three Months Ended June 30, Year Ending December 31, In billions, except per share amounts 2026 2025 2026 Projected Total revenues $ 106.1 $ 98.9 At least $414.0 Diluted earnings per share $ 2.31 $ 0.80 $6.84-$7.04 Adjusted EPS (2) $ 2.58 $ 1.81 $7.90-$8.10 Second quarter GAAP diluted EPS of $2.31 increased from $0.80 in the prior year." exhibit |
| Q2 FY2026 | "The Company is increasing its full-year 2026 GAAP diluted EPS, Adjusted EPS and cash flow from operations guidance to reflect increases in the Health Care Benefits and Pharmacy & Consumer Wellness segments, while maintaining a cautious view for the remainder of the year in light of continued elevated cost trends and the potential for macro headwinds. 1 Consolidated second quarter results Three Months Ended June 30, Six Months Ended June 30, In millions, except per share amounts 2026 2025 Change 2026 2025 Change Total revenues $ 106,096 $ 98,915 $ 7,181 $ 206,522 $ 193,503 $ 13,019 Operating i" exhibit |
Get this as JSON
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/CVS
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/CVS
Put this date on your page
A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
HTML
<a href="https://veritasdata.dev/company/CVS/"><img src="https://veritasdata.dev/embed/CVS.svg" alt="CVS earnings date" width="240" height="56"></a>
Markdown
[](https://veritasdata.dev/company/CVS/)
Script
<script async src="https://veritasdata.dev/embed/CVS.js"></script>
Get a free key: 100 calls, every company
Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.
curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/CVS"
Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.